Tanaproget
Tanaproget is a synthetic, non-steroidal selective progesterone receptor modulator (SPRM) that has been studied for its potential use in hormonal contraception and hormone replacement therapy. It is known for its high selectivity and potency in binding to the progesterone receptor.
Mechanism of Action[edit | edit source]
Tanaproget functions by binding to the progesterone receptor, which is a type of nuclear receptor that regulates the expression of specific genes. Upon binding, Tanaproget modulates the receptor's activity, influencing the transcription of genes involved in the reproductive system and other physiological processes.
Pharmacology[edit | edit source]
Tanaproget exhibits high affinity and selectivity for the progesterone receptor, distinguishing it from other SPRMs. This selectivity reduces the likelihood of off-target effects, making it a promising candidate for therapeutic applications. The compound has been shown to have potent progestational activity in various preclinical models.
Clinical Applications[edit | edit source]
Hormonal Contraception[edit | edit source]
Tanaproget has been investigated as a potential component of hormonal contraception due to its ability to effectively modulate the menstrual cycle and inhibit ovulation. Its high selectivity for the progesterone receptor suggests it could offer a favorable side effect profile compared to other contraceptive agents.
Hormone Replacement Therapy[edit | edit source]
In hormone replacement therapy, Tanaproget may be used to alleviate symptoms associated with menopause by compensating for decreased levels of endogenous progesterone. Its selective action on the progesterone receptor could provide therapeutic benefits while minimizing adverse effects.
Research and Development[edit | edit source]
Tanaproget is still under investigation, and its clinical efficacy and safety are being evaluated in ongoing studies. The compound's unique properties continue to make it a subject of interest in the field of reproductive health and endocrinology.
See Also[edit | edit source]
- Selective progesterone receptor modulator
- Hormonal contraception
- Hormone replacement therapy
- Progesterone receptor
References[edit | edit source]
External Links[edit | edit source]
-
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
